DUSKEY, JASON THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 3.731
AS - Asia 2.072
EU - Europa 1.996
SA - Sud America 265
AF - Africa 42
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.112
Nazione #
US - Stati Uniti d'America 3.688
IT - Italia 893
CN - Cina 683
SG - Singapore 634
GB - Regno Unito 327
HK - Hong Kong 294
BR - Brasile 221
SE - Svezia 167
VN - Vietnam 162
DE - Germania 134
RU - Federazione Russa 131
FI - Finlandia 76
FR - Francia 60
ID - Indonesia 60
KR - Corea 55
NL - Olanda 35
TR - Turchia 35
BG - Bulgaria 34
IN - India 27
CA - Canada 25
JP - Giappone 24
MY - Malesia 24
AR - Argentina 22
ES - Italia 17
LT - Lituania 17
UA - Ucraina 17
ZA - Sudafrica 17
PL - Polonia 16
IE - Irlanda 14
AT - Austria 11
BD - Bangladesh 11
BE - Belgio 11
MX - Messico 11
IQ - Iraq 10
RO - Romania 10
PK - Pakistan 9
CH - Svizzera 7
EC - Ecuador 7
IL - Israele 7
MA - Marocco 7
AE - Emirati Arabi Uniti 5
UZ - Uzbekistan 5
EG - Egitto 4
GR - Grecia 4
TN - Tunisia 4
TW - Taiwan 4
CL - Cile 3
CO - Colombia 3
IR - Iran 3
SA - Arabia Saudita 3
VE - Venezuela 3
AM - Armenia 2
AN - Antille olandesi 2
AU - Australia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TZ - Tanzania 1
YE - Yemen 1
Totale 8.112
Città #
Santa Clara 584
Singapore 402
Fairfield 365
Ashburn 352
Hong Kong 288
Chandler 286
Hefei 275
Woodbridge 166
Seattle 149
Cambridge 142
Modena 140
Houston 137
Southend 132
London 130
Wilmington 128
Nyköping 125
New York 101
Los Angeles 98
Beijing 95
Bologna 85
Dallas 83
Chicago 65
Munich 58
Seoul 53
Helsinki 52
Jakarta 50
Shanghai 47
Ho Chi Minh City 46
Hanoi 42
Reggio Emilia 41
San Diego 41
Ann Arbor 38
Moscow 34
Milan 33
Princeton 33
Sofia 33
Falls Church 31
Rome 29
Council Bluffs 25
São Paulo 22
Lauterbourg 21
Buffalo 19
Dearborn 18
Parma 18
Frankfurt am Main 17
Salt Lake City 16
Turku 16
Jacksonville 15
Kent 15
Castrezzato 14
Elk Grove Village 14
Nuremberg 14
The Dalles 14
Des Moines 13
Tokyo 13
Warsaw 13
Brooklyn 12
Dong Ket 12
Johannesburg 12
Redondo Beach 12
Tampa 12
Ankara 11
Dublin 11
Florence 11
Guangzhou 11
Phoenix 11
Redwood City 11
Brussels 10
Düsseldorf 10
Eugene 10
Izmir 10
Portsmouth 10
Shenzhen 10
Stockholm 10
Wuhan 10
Da Nang 9
Montreal 9
Amsterdam 8
Haiphong 8
Naples 8
Orem 8
Turin 8
Vienna 8
Atlanta 7
Boardman 7
Catania 7
Denver 7
Hounslow 7
Istanbul 7
Lappeenranta 7
Ninh Bình 7
Padova 7
Rio de Janeiro 7
Brasília 6
Columbus 6
Como 6
Kilburn 6
Mountain View 6
Nanjing 6
Salvador 6
Totale 5.670
Nome #
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 316
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 263
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 257
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 256
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 240
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 233
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 231
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 219
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 216
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 214
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 204
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 203
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 203
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 194
Microfluidic technology for the production of hybrid nanomedicines 193
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment 186
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 175
Nanoparticle ligand presentation for targeting solid tumors 170
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? 168
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 164
Tween® preserves enzyme activity and stability in PLGA nanoparticles 161
Challenges of enzyme therapy: Why two players are better than one 157
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier 157
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 155
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 151
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 151
Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver 149
Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery 148
Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties 145
Analysis of Molecular Parameters Determining the Antimalarial Activity of Polymer-Based Nanomimics 145
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 143
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 140
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 136
Tunneling Nanotubes: A New Target for Nanomedicine? 134
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 132
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 129
Chaperonin–Dendrimer Conjugates for siRNA Delivery 129
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs 126
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges 121
New concepts to fight oxidative stress: Nanosized three-dimensional supramolecular antioxidant assemblies 120
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress 118
PH-responsive PDMS-b-PDMAEMA micelles for intracellular anticancer drug delivery 116
Nanomedicines for brain diseases: Where we are and where we are going 112
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression 110
Miniaturization of gene transfection assays in 384- and 1536-well microplates 110
PH-Triggered Reversible Multiple Protein-Polymer Conjugation Based on Molecular Recognition 107
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 107
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery 106
Quantitative comparison of the protein corona of nanoparticles with different matrices 98
Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles 97
Totale 8.215
Categoria #
all - tutte 41.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021561 0 0 0 0 0 102 95 80 62 93 77 52
2021/2022751 55 61 39 39 58 54 36 53 102 69 97 88
2022/2023797 94 80 56 77 79 108 24 85 98 19 41 36
2023/2024699 31 60 46 57 123 93 42 81 18 34 22 92
2024/20252.530 87 43 63 161 448 326 208 164 286 114 263 367
2025/20261.950 328 195 370 473 522 62 0 0 0 0 0 0
Totale 8.215